Source disclosure: February 10, 2026
KOBAYASHI PHARMACEUTICAL CO.,LTD. [4967.T]
TOKYO, Feb 18 (Pulse News Wire) – Kobayashi Pharmaceutical Co., Ltd. (4967.T) reported consolidated results for fiscal year 2025 ending December.
1% YoY). 9 billion (-40.0%). net profit attributable to shareholders was ¥3.66 billion (-63.7%).
3%. For the next fiscal year, the company forecasts 4%).
Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.
AI-translated content. 🟢 Confidence: High See terms •Financial results — FY2025/12 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥165,742M | +0.1% |
| Operating profit | ¥14,923M | -40.0% |
| Net profit | ¥3,656M | -63.7% |
Next period forecast
Revenue
¥173,000M
+4.4%Op. profit
¥12,500M
-16.2%Net profit
¥10,000M
+173.5%Source: TDNet filing · Figures in millions of yen
💬 Help us improve translation quality
Notice any errors in this article? Let us know with one click.